dipyrone and Abortion, Spontaneous

dipyrone has been researched along with Abortion, Spontaneous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Beck, E; Dathe, K; Frank, J; Hultzsch, S; Padberg, S; Schaefer, C1
Arnon, J; Bar-Oz, B; Beer, M; Berkovitch, M; Clementi, M; Di Giantonio, E; Greenberg, R; Merlob, P; Ornoy, A; Zimmerman, DM1

Other Studies

2 other study(ies) available for dipyrone and Abortion, Spontaneous

ArticleYear
Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort.
    BMC pregnancy and childbirth, 2022, Aug-26, Volume: 22, Issue:1

    Topics: Abortion, Spontaneous; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Dipyrone; Drug-Related Side Effects and Adverse Reactions; Ductus Arteriosus; Ductus Arteriosus, Patent; Female; Humans; Infant, Newborn; Oligohydramnios; Pregnancy; Stillbirth

2022
Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study.
    European journal of obstetrics, gynecology, and reproductive biology, 2005, Apr-01, Volume: 119, Issue:2

    Topics: Abortion, Spontaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Congenital Abnormalities; Dipyrone; Female; Humans; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Risk Factors

2005